HSIL
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL) (NCT03721978) | Inovio Pharmaceuticals | 2019-02-28 |
| Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection (NCT03239223) | Antiva Biosciences | 2018-01-01 |
| REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL) (NCT03185013) | Inovio Pharmaceuticals | 2017-06-28 |
Track HSIL automatically
Every clearance here is in the API, with alerts when new ones post.